Cullinan Therapeutics Inc. – Indentures

NASDAQ: CGEM
Share price (6/3/26): $15.21
Market cap (6/3/26): $935 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from S-3ASR 54 pages Cullinan Therapeutics, Inc. and [ ], as Trustee Indenture Dated as of [ ], [ ]

from S-3 2 pages Indenture or similar

from S-3 54 pages Cullinan Oncology, Inc. and [ ], as Trustee Indenture Dated as of [ ], [ ]

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from 10-K 19 pages Registration Rights Agreement

from S-1/A 19 pages Registration Rights Agreement

from S-1/A 2 pages Indenture or similar

from S-1 69 pages Third Amended and Restated Limited Liability Company Agreement of Cullinan Oncology, LLC a Delaware Limited Liability Company Dated as of December 16, 2020

from DRS 100 pages Second Amended and Restated Limited Liability Company Agreement of Cullinan Oncology, LLC a Delaware Limited Liability Company Dated as of October 4, 2019